Ioana D. Olaru

Antimicrobial resistance and COVID-19: Intersections and implications

Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid et al. · eLife · 2021 · 339 citations · Full text

Public Health Challenges, Antibiotic Resistance, Covid-19 +23

What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis

Jan Heyckendorf, Sönke Andres, Claudio U. Köser et al. · Antimicrobial Agents and Chemotherapy · 2017 · 103 citations · Full text

Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

Brian Godman, Holly McCabe, Trudy Leong et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2020 · 86 citations · Full text

Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model

Jan Heyckendorf, Sebastian Marwitz, Maja Reimann et al. · European Respiratory Journal · 2021 · 56 citations · Full text

Time to Culture Positivity and Sputum Smear Microscopy during Tuberculosis Therapy

Ioana D. Olaru, Jan Heyckendorf, Susanne Grossmann et al. · PLoS ONE · 2014 · 46 citations · Full text